Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
Rapamycin (RAPA), an immunosuprpressive drug used extensively to prevent graft rejection in transplant patients, has been reported to inhibit adipogenesis in vitro. In this study, we investigated the anti-obesity effects of RAPA in C57BL/6J mice on a high-fat diet (HFD). Mice treated with RAPA (2 mg...
Main Authors: | Geng-Ruei Chang, Yi-Shin Chiu, Ying-Ying Wu, Wen-Ying Chen, Jiunn-Wang Liao, Te-Hsin Chao, Frank Chiahung Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319312307 |
Similar Items
-
Exercise Affects Blood Glucose Levels and Tissue Chromium Distribution in High-Fat Diet-Fed C57BL6 Mice
by: Geng-Ruei Chang, et al.
Published: (2020-04-01) -
α-Lactalbumin ameliorates hepatic lipid metabolism in high-fat-diet induced obese C57BL/6J mice
by: Haoran Chen, et al.
Published: (2020-12-01) -
Study of the blockage effect of rapamycin in high fat diet-induced obesity mice
by: Geng-Ruei Chang, et al. -
The effects of rapamycin on olanzapine induced obesity in C57BL/6JNarl mice
by: Ching-Pin Chen, et al.
Published: (2011) -
Casein glycomacropeptide hydrolysates ameliorate hepatic insulin resistance of C57BL/6J mice challenged with high-fat diet
by: Jia-jia Song, et al.
Published: (2018-06-01)